AI주식인사이트AI Stock Insight
C

셀바스헬스케어

208370KOSDAQ

49.6 / 100

Reference Date: 2026-09-08

Financial Score22.0 / 40
News Sentiment14.6 / 25
Momentum3.0 / 20
Disclosure10.0 / 15
AI Analysis: the debt ratio is very low with excellent financial health but Operating Profit is on a declining trend. Declined 10.0% over the past month, and news sentiment is neutral.

Company InformationBased on 2025 Annual Report

Business Overview

Selbas Healthcare is a digital health specialist company with two business units: medical diagnostic devices 'ACCUNIQ' and assistive technology for visually impaired individuals 'HIMS'. ACCUNIQ's flagship product, the body composition analyzer 'BC380', boasts 98% accuracy, while HIMS's BrailleSense Polaris utilizes Google Mobile Services certification with advanced IT technology. The company is expanding its global market through subsidiaries in the U.S. and China, as well as an established international distribution network.

Number of Employees

139people

Average Salary

49.5M KRW

Score Calculation Basis

Detailed Financial Score

PER
16.16Industry Average 15.003.0Point

Higher than industry avg (caution)

PBR
0.88Industry Average 1.205.5Point

Lower than industry avg (good)

ROE
5.77Industry Average 8.002.5Point

Below industry avg

Debt Ratio
4.02Industry Average 100.008.0Point

Half of industry avg (excellent)

Trend 2023~20253.0 / 10 points
Revenue Growth Rate
1.0 / 3

Avg ▲1.8% (2-year basis)

Operating Profit Growth Rate
0.0 / 3

Avg ▼53.5% (2-year basis)

ROE Trend
2.0 / 4

Avg ROE 7.3% (declining, 3yr)

Detailed News Sentiment

3 totalPositive 1Neutral 2Negative 0Average Sentiment Score 58.3

Detailed Momentum

52-week position1.0Point

Near 52w low (5%, downtrend)

Current 2,440Won52-week high 6,65052-week low 2,185
1-month return1.0Point

1m -9.96% (falling)

Volume trend1.0Point

Volume dry-up

Detailed Disclosure

1 totalPositive 0Neutral 1Negative 0
  • Neutral반기보고서 (2026.06)2026-08-14